X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

API PA by API PA
21st July 2025
in News
ChiRhoClin LogiCare3PL Partners for Drug Distribution

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

LogiCare3PL, a division of BioCare, Inc., has announced a partnership with ChiRhoClin, Inc., a recognized leader in pancreatic and gastrointestinal diagnostics. This strategic move underscores both organizations’ dedication to ensuring the reliable, timely delivery of critical diagnostic treatments to patients nationwide. The company will be the only third-party logistics (3PL) provider for ChiRhoStim®, ChiRhoClin’s flagship product.

As a nationally accredited orphan drug logistics expertise, LogiCare3PL brings extensive expertise in handling high-value, small-batch pharmaceuticals. ChiRhoClin, LogiCare3PL partners will enhance ChiRhoClin’s distribution capabilities, while maintaining the respective mutual commitment to an exceptional focus on high-touch service and patient-centered care. With the support of LogiCare3PL, ChiRhoStim® distribution will be carried out through a network with uncompromising commitments to accuracy and reliability.

Kevin Kissling, Vice President and General Manager of LogiCare3PL, expressed pride in supporting ChiRhoClin’s vital mission. “We’re proud to support ChiRhoClin in distributing ChiRhoStim®, a diagnostic product that plays a vital role in patient care,” Kissling said. “Our team appreciates the importance of reliability and precision in handling sensitive therapies like ChiRhoStim®, and we are committed to delivering a seamless and dependable experience for ChiRhoClin’s customers.”

Supporting the commitment are LogiCare3PL’s two fully accredited distribution centres, which have been located in Tempe, Arizona, and Olive Branch, Mississippi. The distribution centers are customised for high-value pharmaceutical logistics, precision, and compliance, fully accredited by the National Association of Boards of Pharmacy® (NABP®), compliant with cGMP regulations and ready to support both domestic and international distribution requirements as ChiRhoClin, LogiCare3PL partners for ChiRhoStim® distribution.

Skip Purich, CEO of ChiRhoClin, Inc., highlighted the value of the partnership, stating, “The LogiCare3PL team has been a proactive and engaged partner as we prepared to distribute ChiRhoStim® through the company’s distribution network. Their experience in orphan drug logistics has been critical to establishing a strong foundation for this launch, and we’re confident this partnership will deliver a high level of service to our customers.”

Previous Post

Strategies for the Resilient Perinatal Drug Supply Chain

Next Post

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Merck to Acquire Verona

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In